Published in Heart on October 01, 2014
Metabolic Determinants of the Progression of Aortic Stenosis (PROGRESSA) | NCT01679431
Aortic Stenosis: Changing Disease Concepts. J Cardiovasc Ultrasound (2015) 0.81
BNP during exercise: a novel use for a familiar biomarker in aortic stenosis. Heart (2014) 0.77
Asymptomatic severe aortic stenosis with normal left ventricular function - A review. Indian Heart J (2016) 0.75
Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis. PLoS One (2017) 0.75
Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis. Pediatr Cardiol (2015) 0.75
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol (2008) 5.19
Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med (2012) 4.76
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr (2010) 3.70
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology (2004) 3.50
Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol (2009) 3.49
Distorted views of biodiversity: spatial and temporal bias in species occurrence data. PLoS Biol (2010) 3.33
Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol (2008) 3.32
Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation (2007) 3.24
Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol (2012) 3.15
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol (2003) 3.02
Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol (2011) 2.83
Prevention of ventilator-associated pneumonia and ventilator-associated conditions: a randomized controlled trial with subglottic secretion suctioning. Crit Care Med (2015) 2.79
Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol (2008) 2.58
Low-flow, low-gradient severe aortic stenosis despite normal ejection fraction is associated with severe left ventricular dysfunction as assessed by speckle-tracking echocardiography: a multicenter study. Circ Cardiovasc Imaging (2011) 2.58
Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol (2012) 2.42
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation (2009) 2.40
Perception of pain in the minimally conscious state with PET activation: an observational study. Lancet Neurol (2008) 2.39
The infective endocarditis team: recommendations from an international working group. Heart (2013) 2.39
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging (2013) 2.35
Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol (2005) 2.33
Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol (2005) 2.31
Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation (2006) 2.29
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr (2010) 2.25
Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J (2008) 2.22
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr (2008) 2.19
Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation (2010) 2.13
Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation. J Heart Valve Dis (2012) 2.08
Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology (2008) 2.07
Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation (2003) 2.06
Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol (2009) 2.05
Pivotal role of bedside Doppler echocardiography in the assessment of patients with acute heart failure and mitral regurgitation. Cardiology (2009) 2.03
Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol (2011) 2.02
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension (2009) 2.00
Comparison of peak flow velocity through the left ventricular outflow tract and effective orifice area indexed to body surface area in Golden Retriever puppies to predict development of subaortic stenosis in adult dogs. J Am Vet Med Assoc (2014) 2.00
The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med (2004) 1.99
Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr (2002) 1.98
Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon: practical implications with regard to quantification of aortic stenosis severity. J Am Coll Cardiol (2003) 1.89
The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J (2012) 1.88
Management of mobile right heart thrombi: a prospective series. Int J Cardiol (2005) 1.85
Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol (2010) 1.81
Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J (2009) 1.81
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol (2013) 1.79
Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation (2007) 1.78
Prosthesis-patient mismatch: an update. Curr Cardiol Rep (2011) 1.77
Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Interv (2009) 1.77
European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr (2008) 1.77
Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation (2009) 1.76
Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2013) 1.72
Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J (2010) 1.71
Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol (2008) 1.71
Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol (2010) 1.68
The use of pocket-size imaging devices: a position statement of the European Association of Echocardiography. Eur J Echocardiogr (2011) 1.67
Continued global left ventricular remodeling is not the sole mechanism responsible for the late recurrence of ischemic mitral regurgitation after restrictive annuloplasty. J Am Soc Echocardiogr (2009) 1.63
Impact of anesthesia on echocardiographic evaluation of systolic and diastolic function in rats. J Am Soc Echocardiogr (2006) 1.63
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed) (2016) 1.61
Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv (2012) 1.60
Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coll Cardiol (2012) 1.60
Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging (2011) 1.59
Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58
Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J (2009) 1.57
Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation (2006) 1.55
Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation (2012) 1.54